BLPH
Price:
$0.012
Market Cap:
$146.79K
Bellerophon Therapeutics, Inc. is a U.S.-based clinical-stage pharmaceutical company primarily focused on developing novel therapies for various cardiopulmonary conditions. Its flagship product is INOpulse, a proprietary platform designed to deliver pulsatile nitric oxide, specifically targeting pulmonary hypertension (PH). The company is actively advancing the development of INOpulse across multiple indications: Currently, INOpulse is undergoing a Phase 3 clinical trial for pulmonary hypertension linked to fibrotic interstitial lung disease. It has successfully completed a Phase 2a trial for pulmonary hypertension tied to chronic obstructive pulmonary disease. Furthermore, a Phase 2 dose es...[Read more]
Industry
Biotechnology
IPO Date
2015-02-13
Stock Exchange
NASDAQ
Ticker
BLPH
According to Bellerophon Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Bellerophon Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), BLPH's Dividend Yield was at its highest in in the December 2013 quarter at 0%. The Dividend Yield was at its lowest in in the December 2013 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Bellerophon Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2022 | 0% | 0% |
| 2021 | 0% | 0% |
| 2020 | 0% | 0% |
| 2019 | 0% | 0% |
| 2018 | 0% | 0% |
| 2017 | 0% | 0% |
| 2016 | 0% | 0% |
| 2015 | 0% | 0% |
| 2014 | 0% | 0% |
| 2013 | 0% | 0% |
The current Dividend Yield of Bellerophon Therapeutics, Inc. (BLPH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Bellerophon Therapeutics, Inc.’s Dividend Yield is less than Atlantic International Corp. (0%), less than Akerna Corp. (0%), less than Histogen Inc. (0%), less than Virios Therapeutics, Inc. (0%), less than Seelos Therapeutics, Inc. (0%), less than TFF Pharmaceuticals, Inc. (0%), less than Immatics N.V. (0%), less than TC Biopharm (Holdings) Plc (0%), less than BioCardia, Inc. (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $47.61M | |
| 0% | $162.32K | |
| 0% | $85.44K | |
| 0% | $206.50K | |
| 0% | $214.97K | |
| 0% | $288.80K | |
| 0% | $1.26B | |
| 0% | $256.50K | |
| 0% | $5.10M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bellerophon Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bellerophon Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Bellerophon Therapeutics, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Bellerophon Therapeutics, Inc. (BLPH)?
What is the highest Dividend Yield for Bellerophon Therapeutics, Inc. (BLPH)?
What is the 3-year average Dividend Yield for Bellerophon Therapeutics, Inc. (BLPH)?
What is the 5-year average Dividend Yield for Bellerophon Therapeutics, Inc. (BLPH)?
How does the current Dividend Yield for Bellerophon Therapeutics, Inc. (BLPH) compare to its historical average?